$449 Million is the total value of Ghost Tree Capital, LLC's 43 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 166.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QQQ | New | INVESCO QQQ TRput | $31,374,000 | – | 100,000 | +100.0% | 6.99% | – |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $30,024,000 | +378.6% | 1,350,000 | +217.6% | 6.69% | +269.0% |
| RCKT | Buy | ROCKET PHARMACEUTICALS INC | $27,420,000 | +199.9% | 500,000 | +25.0% | 6.11% | +131.2% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $18,590,000 | – | 325,000 | +100.0% | 4.14% | – |
| ARVN | Buy | ARVINAS INC | $17,411,000 | +268.7% | 205,000 | +2.5% | 3.88% | +184.2% |
| TGTX | Buy | TG THERAPEUTICS INC | $13,005,000 | +143.0% | 250,000 | +25.0% | 2.90% | +87.3% |
| TVTX | New | TRAVERE THERAPEUTICS INC | $12,946,000 | – | 475,000 | +100.0% | 2.88% | – |
| COGT | New | COGENT BIOSCIENCES INC | $12,353,000 | – | 1,100,000 | +100.0% | 2.75% | – |
| MRTX | New | MIRATI THERAPEUTICS INCcall | $10,982,000 | – | 50,000 | +100.0% | 2.45% | – |
| XENE | Buy | XENON PHARMACEUTICALS INC | $10,766,000 | +199.2% | 700,000 | +115.4% | 2.40% | +130.7% |
| KURA | Buy | KURA ONCOLOGY INC | $10,615,000 | +54.0% | 325,000 | +44.4% | 2.36% | +18.7% |
| ISEE | Buy | IVERIC BIO INC | $9,501,000 | +68.5% | 1,375,000 | +37.5% | 2.12% | +29.9% |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $8,505,000 | – | 500,000 | +100.0% | 1.90% | – |
| HLXA | New | HELIX ACQUISITION CORP | $5,685,000 | – | 500,000 | +100.0% | 1.27% | – |
| VRNA | Buy | VERONA PHARMA PLCsponsored ads | $5,670,000 | +12.8% | 810,000 | +0.6% | 1.26% | -13.1% |
| VTGN | New | VISTAGEN THERAPEUTICS INC | $4,734,000 | – | 2,440,000 | +100.0% | 1.06% | – |
| ACRS | New | ACLARIS THERAPEUTICS INC | $4,206,000 | – | 650,000 | +100.0% | 0.94% | – |
| MRNA | New | MODERNA INCput | $3,656,000 | – | 35,000 | +100.0% | 0.82% | – |
| CRIS | New | CURIS INC | $3,481,000 | – | 425,000 | +100.0% | 0.78% | – |
| SRRA | New | SIERRA ONCOLOGY INC | $3,206,000 | – | 200,000 | +100.0% | 0.71% | – |
| CTIC | New | CTI BIOPHARMA CORP | $2,415,000 | – | 750,000 | +100.0% | 0.54% | – |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $1,956,000 | +364.6% | 400,000 | +300.0% | 0.44% | +257.4% |
| APVO | New | APTEVO THERAPEUTICS INC | $1,833,000 | – | 50,000 | +100.0% | 0.41% | – |
| OTIC | New | OTONOMY INC | $1,294,000 | – | 200,000 | +100.0% | 0.29% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-02-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.